Barclays PLC Boosts Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Barclays PLC grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 21.8% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 306,809 shares of the medical instruments supplier’s stock after buying an additional 54,920 shares during the quarter. Barclays PLC’s holdings in DENTSPLY SIRONA were worth $8,301,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. First Eagle Investment Management LLC lifted its holdings in DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after purchasing an additional 3,283,965 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after buying an additional 1,308,411 shares in the last quarter. Cooke & Bieler LP boosted its position in DENTSPLY SIRONA by 16.2% during the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after acquiring an additional 1,046,105 shares during the last quarter. Invenomic Capital Management LP purchased a new stake in DENTSPLY SIRONA during the 3rd quarter valued at about $23,724,000. Finally, National Bank of Canada FI raised its holdings in DENTSPLY SIRONA by 684.6% in the 2nd quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier’s stock valued at $21,586,000 after acquiring an additional 764,700 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $19.19 on Wednesday. The stock has a fifty day simple moving average of $21.18 and a 200-day simple moving average of $24.11. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a market cap of $3.81 billion, a PE ratio of -9.27, a P/E/G ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same quarter last year, the firm posted $0.49 earnings per share. DENTSPLY SIRONA’s revenue was up .4% compared to the same quarter last year. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.34%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on XRAY. Morgan Stanley lowered their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday. Evercore ISI reduced their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Mizuho started coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price for the company. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $27.91.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.